Chromosome Disorders: Clinical Trials

24 trials for Chromosome Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 completed. 24 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 424Completed 24

Follow Chromosome Disorders: new trials by email Literature Review of Chromosome Disorders trials Research Report on Chromosome Disorders

Trials (filtered) newest first · largest first

All 24 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fluoxetine Treatment of Depression in Down Syndrome
Fluoxetine - Down Syndrome, Depression
Phase 4CompletedMassachusetts General Hospital42022-12-052025-03-30
Metformin in Children With Fragile X Syndrome
Metformin, Placebo - Fragile X Syndrome, Metformin
Phase 4CompletedChildren's Hospital of Fudan University372021-12-292026-08-25
Buspirone Treatment of Anxiety in Williams Syndrome
Buspirone - Williams Syndrome, Anxiety
Phase 4CompletedMassachusetts General Hospital202021-08-012024-12-03
Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
Guanfacine Extended Release, Placebo - Prader-Willi Syndrome, Aggression
Phase 4CompletedMaimonides Medical Center152020-12-172024-08-19
Evaluating Treatment of ADHD in Children With Down Syndrome
Quillivant XR, Placebo - Down Syndrome, ADHD
Phase 4CompletedChildren's Hospital Medical Center, Cincinnati442020-10-022026-11-02
TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY
Testosterone Cypionate 200 Milligram/Milliliter Injectable Solution, Placebo injectable saline - Klinefelter Syndrome
Phase 4CompletedUniversity of Colorado, Denver722017-11-062022-05-06
GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body Composition
Growth hormone, Placebo - Prader-Willi Syndrome
Phase 4CompletedCorporacion Parc Tauli302017-06-192021-01-27
Human Fibrinogen Concentrate in Pediatric Cardiac Surgery
RiaStAP, Saline - Hypofibrinogenemia, Afibrinogenemia
Phase 4CompletedNicklaus Children's Hospital f/k/a Miami Children's Hospital302017-06-012021-09-16
Oxygen Versus Medical Air for Treatment of CSA in Prader Will Syndrome
Medical Air vs Oxygen - Sleep Apnea, Central, Prader-Willi Syndrome
Phase 4CompletedThe Hospital for Sick Children92016-09-012025-06-08
Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.
Somatropin - Short Stature, Idiopathic, Infant, Small for Gestational Age
Phase 4CompletedLG Life Sciences1162016-08-112019-01-03
Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome
Lovastatin, Placebo - Fragile X Syndrome, Genetic Diseases
Phase 4CompletedUniversity of California, Davis302016-01-012019-09-11
Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment
testosterone cypionate 200mg/ml - Klinefelter Syndrome
Phase 4CompletedUniversity of Colorado, Denver202015-05-082020-04-15
First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study
Blood sampling - Idiopathic Growth Hormone Deficiency, Turner Syndrome
Phase 4CompletedMerck KGaA, Darmstadt, Germany4582011-09-012014-01-16
Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents
Norditropin NordiFlex® - Growth Hormone Disorder, Growth Hormone Deficiency in Children
Phase 4CompletedNovo Nordisk A/S1032010-11-012017-02-27
Riluzole in Fragile X Syndrome
Riluzole - Fragile X Syndrome
Phase 4CompletedIndiana University62009-04-012017-04-18
Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?
Growth hormone (Genotonorm® or Omnitrope®), DEXA, blood tests, H.G.P.O, osseous age., biopsy - Prader-Willi Syndrome, Growth Hormone Deficiency
Phase 4CompletedUniversity Hospital, Toulouse1112009-01-012021-09-24
Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism
17 B estradiol orally, 17 B estradiol - Turner Syndrome, Hypogonadism
Phase 4CompletedNemours Children's Clinic412009-01-012023-05-16
Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome
Memantine, Placebo - Down Syndrome
Phase 4CompletedUniversity of Colorado, Denver422008-07-012013-02-01
Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome
Humatrope - Turner Syndrome
Phase 4CompletedEli Lilly and Company692005-12-012017-03-31
Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome
estradiol - Turner Syndrome
Phase 4CompletedLine Cleemann432005-06-012013-06-14

Showing 20 of 24. Sign in to see all of them.

Narrower conditions

Turner Syndrome (10)  ·  Genetic Diseases, Inborn (5)  ·  Dwarfism, Pituitary (4)  ·  Prader-Willi Syndrome (4)  ·  Down Syndrome (3)  ·  Fragile X Syndrome (3)  ·  Intellectual Disability (2)  ·  Klinefelter Syndrome (2)  ·  Neurobehavioral Manifestations (2)  ·  Abnormalities, Multiple (1)  ·  Afibrinogenemia (1)  ·  Aggression (1)  ·  Anxiety Disorders (1)  ·  Attention Deficit Disorder with Hyperactivity (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (24)  ·  Congenital Abnormalities (23)  ·  Genetic Diseases, Inborn (19)  ·  Sex Chromosome Disorders (15)  ·  Nervous System Diseases (14)  ·  Endocrine System Diseases (13)  ·  Cardiovascular Diseases (12)  ·  Disorders of Sex Development (12)  ·  Female Urogenital Diseases (12)  ·  Female Urogenital Diseases and Pregnancy Complications (12)  ·  Gonadal Disorders (12)  ·  Heart Diseases (12)  ·  Male Urogenital Diseases (12)  ·  Sex Chromosome Disorders of Sex Development (12)

Interventions

Human Growth Hormone (7)  ·  Growth Hormone (3)  ·  Estradiol (2)  ·  Absorptiometry, Photon (1)  ·  Biopsy (1)  ·  Blood Specimen Collection (1)  ·  Buspirone (1)  ·  Estrogens (1)  ·  Fibrinogen (1)  ·  Fluoxetine (1)  ·  Guanfacine (1)  ·  Hematologic Tests (1)  ·  Lovastatin (1)  ·  Memantine (1)  ·  Metformin (1)

Sponsors

Merck KGaA, Darmstadt, Germany (3)  ·  Novo Nordisk A/S (3)  ·  University of Colorado, Denver (3)  ·  Massachusetts General Hospital (2)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Children's Hospital of Fudan University (1)  ·  Corporacion Parc Tauli (1)  ·  Eli Lilly and Company (1)  ·  Indiana University (1)  ·  LG Life Sciences (1)  ·  Line Cleemann (1)  ·  Maimonides Medical Center (1)  ·  Nemours Children's Clinic (1)  ·  Nicklaus Children's Hospital f/k/a Miami Children's Hospital (1)  ·  The Hospital for Sick Children (1)

Countries

United States (12)  ·  France (6)  ·  Canada (3)  ·  Spain (3)  ·  Argentina (2)  ·  Germany (2)  ·  Italy (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Austria (1)  ·  Chile (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)

Top investigators

Shanlee M Davis, MD (2)  ·  Alberto Costa, MD, Ph.D (1)  ·  Anna Esbensen, PhD (1)  ·  Benjamin Handen, MD (1)  ·  Christopher Tirotta, MD (1)  ·  Craig A. Erickson, MD (1)  ·  Deepan Singh, MD (1)  ·  Edward Goldson, MD (1)  ·  Gilles Della Corte (1)  ·  Kathleen Angkustsiri, MD (1)  ·  Line Cleemann, Doctor (1)

Results publications

PMID 10518081, PMID 10599727, PMID 10599729, PMID 12466334, PMID 12629094, PMID 15900109, PMID 21059347, PMID 21398400, PMID 21880799, PMID 22806212, PMID 23567489, PMID 23678038, PMID 23737664, PMID 24406482, PMID 24916642, PMID 26340968, PMID 29618660, PMID 30571546, PMID 31613320, PMID 31908426, PMID 32316911, PMID 34040195, PMID 34045667, PMID 35305111, PMID 38561465, PMID 41291951, PMID 8923853

NIH funding

2009 (1), 2017 (1), K23HD092588 (1), UL1TR001082 (1)